Advertisement
Advertisement
EVO
Evotec SE - ADR
3.03
USDSponsored
+0.04
+1.34%
May 22, 15:48 UTC -4
Closed
After-Market
3.00
-0.03
-1.16%
EVO Earnings Reports
Positive Surprise Ratio
EVO beat 15 of 39 last estimates.
38%
Next Report
Date of Next Report
Aug 13, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/-$0.03
Implied change from Q1 26 (Revenue/ EPS)
--
/-95.65%
Implied change from Q2 25 (Revenue/ EPS)
--
/-87.50%
Evotec SE - ADR earnings per share and revenue
On May 06, 2026, EVO reported earnings of -0.69 USD per share (EPS) for Q1 26, missing the estimate of -0.30 USD, resulting in a -127.72% surprise. Revenue reached 156.64 million, compared to an expected 174.22 million, with a -10.09% difference. The market reacted with a +1.25% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -0.03 USD, with revenue projected to reach -- USD, implying an decrease of -95.65% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
ARS Pharmaceuticals, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.53
Actual
-$0.61
Surprise
-13.81%
ProKidney Corp. Class A Ordinary Shares
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.14
Actual
-$0.14
Surprise
+0.57%
Incannex Healthcare Limited - ADR
Report Date
May 15, 2026 For Q3 26
Estimate
-$0.94
Actual
-$11.22
Surprise
-1088.38%
Marker Therapeutics, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.18
Actual
-$0.16
Surprise
+14.44%
PLUS THERAPEUTICS, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.89
Actual
-$1.05
Surprise
-16.98%
Scienture Holdings, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.08
Surprise
+64.35%
Wellgistics Health, Inc. Common Stock
Report Date
May 19, 2026 For Q1 26
Estimate
-Actual
-$0.07
Surprise
-
Traws Pharma, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.75
Actual
-$0.53
Surprise
+29.78%
60 Degrees Pharmaceuticals, Inc. Common Stock
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.77
Actual
-$1.28
Surprise
-65.12%
AIM ImmunoTech Inc.
Report Date
May 15, 2026 For Q1 26
Estimate
-$0.37
Actual
-$0.56
Surprise
-52.53%
FAQ
What were Evotec SE - ADR's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Evotec SE - ADR reported EPS of -$0.69, missing estimates by -127.72%, and revenue of $156.64M, -10.09% below expectations.
How did the market react to Evotec SE - ADR's Q1 2026 earnings?
The stock price moved up 1.25%, changed from $3.20 before the earnings release to $3.24 the day after.
When is Evotec SE - ADR expected to report next?
The next earning report is scheduled for Aug 13, 2026.
What are the forecasts for Evotec SE - ADR's next earnings report?
Based on --
analysts, Evotec SE - ADR is expected to report EPS of -$0.03 and revenue of -- for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement